The aim of this study was to assess the relationship between superior vena cava (SVC) diameter, collapsibility and central venous pressure (CVP) in cardiac surgical patients. SVC maximum and minimum diameters, plus collapsibility with ventilation, were measured with transoesophageal echocardiography in the mid-oesophageal bicaval view with M-mode. Simultaneously, CVP was measured via the right atrial port of a pulmonary artery catheter. Measurements were possible in 91 out of 92 patients. The median CVP was 10 mmHg with a range of 2 to 19 mmHg. There was a weak, but statistically significant, correlation between CVP and SVC collapsibility index (r=-0.21, P=0.049). There was no statistically significant correlation between maximum SVC diameter and CVP. Maximum SVC diameter was statistically significantly correlated with weight (Pearson's r=0.28, P=0.008). There was no statistically significant correlation between CVP and age or body dimensions. Our findings indicate that SVC diameter and collapsibility are easily measured with transoesophageal echocardiography but do not reliably reflect CVP in anaesthetised cardiac surgical patients.
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Central venous pressure (CVP) measurement is fundamental in perioperative medicine and is often achieved invasively with a central venous catheter (CVC). However, CVC insertion is not without risk, with early mechanical complications at the time of insertion and later infective and thrombotic complications occurring in up to 20% of patients 1 .
CVP can be estimated non-invasively by clinical examination of the jugular venous pressure, but this may be inaccurate 2 , and is often difficult to visualise in anaesthetised critically ill supine patients 3 .
Echocardiography has been used to estimate CVP, with particular emphasis on the inferior vena cava (IVC) diameter and collapsibility with respiration. In general, an IVC diameter of <21 mm with >50% collapsibility suggests a CVP of 0 to 5 mmHg and a dilated IVC >21 mm and <50% collapsibility suggests an elevated CVP of 10 to 20 mmHg 4 . However, there is considerable overlap between normal and abnormal. The IVC is enlarged in several conditions with normal CVP, including with positive pressure ventilation where these variables are less well validated. Many studies have recently questioned the accuracy of this technique 4 .
Given the entirely intrathoracic location of the superior vena cava (SVC), its diameter and collapsibility with positive pressure ventilation is a potentially attractive method of non-invasively estimating CVP. In short, the SVC collapses partly or completely with positive pressure ventilation, depending on the transmural pressure difference between intrathoracic pressure and SVC pressure (CVP). In contrast, increased intrathoracic pressure causes dilation of the intraabdominal portion of the IVC 5 .
The collapsibility of the SVC has been used to estimate intravascular volume and fluid responsiveness in critically ill patients 5 . In addition, accurate estimation of the CVP is a key component of the non-invasive measurement of right ventricular systolic pressure (RVSP), with inaccuracies leading to both under-and overestimation of the RVSP 6 . To date, we are unaware of any data specifically comparing SVC indices with CVP. Nor is this mentioned in guideline statements from echocardiography societies, perhaps because of the difficulty imaging the SVC with transthoracic echocardiography in adult patients 7 . With transoesophageal echocardiography (TOE), the SVC is easy to visualise in almost all patients.
The aim of this study was to assess the relationship between SVC diameter, collapsibility and CVP in cardiac surgical patients.
Methods
The study was approved by the Human and Research and Ethics Committee at the University Hospital, Leuven, Belgium (Project: S56840). Informed consent was waived given that TOE and the pulmonary artery catheter are used routinely in cardiac surgical patients in this institution. This project was part of a larger study on non-invasive estimation of intracardiac pressures with TOE.
Consecutive patients having cardiac surgery, when one of the authors was available, were included in the study.
Patients were excluded if, for whatever reason, both TOE and a pulmonary artery catheter were not used as part of their intraoperative care.
Measurements of the SVC were taken in the midoesophageal bicaval view using M-mode echocardiography, 1 to 2 cm away from the entry point into the right atrium ( Figure 1) .
The maximum and minimum SVC diameters were recorded and the SVC collapsibility index was calculated as: (SVC Maximum Diameter-SVC Minimum Diameter)×100/ SVC Maximum Diameter.
Whilst there are no recommended guidelines on how to measure SVC diameter and collapsibility, this technique is analogous to that recommended when measuring IVC diameter and collapsibility 4 .
Measurements were performed by experienced cardiac anaesthetists with expertise and qualifications in TOE, blinded to invasive CVP measurements, as part of a comprehensive TOE study.
Two different machines were used, depending on availability: Vivid S6 with the 6Tc probe (GE Vingmed Ultrasound, Horten, Norway) and iE33 with the X7-2t probe (Philips Healthcare, Best, the Netherlands).
Simultaneously, CVP was recorded from the right atrial port of the pulmonary artery catheter (Edwards Lifesciences Swan GanzCCOmbo, Ref: 744HF75 thermodilution catheter). Patients were in the supine position with pressure transducers zeroed to atmospheric pressure and located at the mid-thoracic position, half-way between the sternum and bed, as recommended in recent guidelines 8 .
All measurements were taken pre-cardiopulmonary bypass and during a period of stable haemodynamics, with patients ventilated using a tidal volume of 6 to 8 ml/kg with a positive end-expiratory pressure of 5 cmH 2 O, prior to pericardiotomy.
Descriptive statistics, Pearson's correlation coefficients and linear regression lines of best fit were calculated using Stata 12.1 (StataCorp, College Station, Texas, USA). 
Results
Simultaneous measurement of CVP and the SVC dimensions was possible in 91 out of 92 cardiac surgical patients. In one patient, SVC imaging was suboptimal with TOE. Table 1 summarises population variables.
The median CVP in our sample was 10 mmHg with a range of 2 to 19 mmHg.
There was a weak, but statistically significant, correlation between CVP and SVC collapsibility index (Pearson's r=-0.21, P=0.049) (Figure 2 ).
Maximum SVC diameter was statistically significantly correlated with weight (Pearson's r=0.28, P=0.008) (Figure 3 ).
There was no statistically significant correlation between maximum SVC diameter and patient height (Pearson's r= 0.21, P=0.052) or body mass index (Pearson's r=0.20, P=0.066).
There was no statistically significant correlation between maximum SVC diameter and CVP (Pearson's r=0.04, P=0.70). There was no statistically significant correlation between CVP and age or weight or height.
Discussion
Our findings indicate that non-invasive estimation of CVP in cardiac surgical patients cannot accurately be achieved with SVC diameter measurements with TOE. Whilst the SVC is easily measured in almost all patients, there was only a weak relationship between SVC collapsibility and the CVP. As such, non-invasive estimation of CVP is currently not reliable with TOE in cardiac surgical patients undergoing general anaesthesia. It follows that TOE estimates of CVP cannot be used in derived echocardiographic Doppler measurements such as the right ventricular systolic pressure (RVSP), which requires an accurate estimate of CVP.
Whilst many cardiac centres are reducing their use of the pulmonary artery catheter, almost all would insert a CVC into cardiac surgical patients. This remains the reference standard of CVP measurement. We have recently shown that the combination of invasively estimated CVP with a CVC and tricuspid regurgitant jet velocity measurement with TOE allows a reliable and accurate determination of RVSP 9 .
IVC diameter and collapsibility is routine in cardiology laboratories for right atrial pressure estimation with transthoracic echocardiography 4 . However, this has not been well validated with positive pressure ventilation, where the extrathoracic IVC dilates during inspiration with the increased intrathoracic pressure and has reduced collapsibility. We would expect the entirely intrathoracic SVC to collapse with positive pressure ventilation depending on the difference between the intrathoracic and SVC (CVP) pressure. Yet, neither the diameter nor collapsibility of the SVC could reliably predict CVP.
Limitations of this study include that most measurements were performed following sternotomy but pre-pericardiotomy, hence decreasing the changes in intrathoracic pressure with positive pressure ventilation. Another limitation is the observation that both the IVC and SVC undergo craniocaudal and medial/lateral movement with respiration 10 . As a result, M-mode or two-dimensional imaging may not reflect the true long axis of the vessel or the largest diameter. A future study could evaluate the circular short axis area of the IVC or SVC, thus minimising the impact of motion of the cava and loss of the true long axis or largest diameter. This would also account for a vessel that was non-circular but ellipsoid. As yet, this is not a standard measurement. Given most cardiac cases proceed with a CVC, it could be argued that no echocardiographic modality is required for CVP estimation. However, TOE probe insertion may be required in non-cardiac cases at times of unexplained hypotension or cardiovascular collapse, where no CVC is in situ. Estimation of intravascular volume status, filling and pulmonary pressures is fundamental in these settings and our data suggest that CVP and RVSP estimation using SVC diameter and collapsibility is unreliable.
Whilst we have shown that TOE does not reliably estimate CVP using the SVC diameter and collapsibility, this does not discount its potential utility for intravascular volume assessment with other measurements. For example, it may be that SVC collapsibility is a good assessment of fluid responsiveness (unlike the CVP). However, we did not study this. Furthermore, echocardiography potentially provides much other information regarding preload such as stroke volume variation, left and right ventricular size, volume and function, non-invasive estimation of RVSP and left atrial pressure 11 .
Conclusion
In conclusion, SVC diameter and collapsibility are easily measured with TOE but do not reliably reflect CVP in cardiac surgical patients under general anaesthesia.
